^

News and Publications

ASTRO urges increased investment in cancer research in FY2022

November 16, 2021

ASTRO and fellow members of the One Voice Against Cancer (OVAC) coalition have sent a letter to Chairwoman Patty Murray and Ranking Member Roy Blunt of the Senate Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies and Chairwoman Rosa DeLauro and Ranking Member Tom Cole of the House Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies urging a prioritization of funding for cancer research during negotiations over the FY2022 Appropriations bill.

OVAC’s primary request includes $7.609 billion for the National Cancer Institute (NCI), the amount recommended by NCI in its FY2022 professional judgement budget, and $51.733 billion for the National Institutes of Health (NIH), the amount requested in the President’s budget. With NCI experiencing the highest demand for research funding of any of the NIH institutes or Centers, these increases in funding will help foster the potential for new breakthroughs.

OVAC additionally calls for $559 million for the Centers for Disease Division of Cancer Prevention and Control. This program provides critical resources to communities that help ensure access to vital cancer prevention programs for at-risk, low-income patients.